Robert W. Baird reissued their outperform rating on shares of Envision Healthcare (NYSE:EVHC) in a report published on Wednesday. The firm currently has a $50.00 target price on the stock, up from their previous target price of $45.00.
EVHC has been the subject of several other research reports. ValuEngine downgraded shares of Envision Healthcare from a buy rating to a hold rating in a research report on Sunday, December 31st. Cantor Fitzgerald reiterated a hold rating and issued a $30.00 price target on shares of Envision Healthcare in a research report on Tuesday, November 14th. Credit Suisse Group started coverage on shares of Envision Healthcare in a research report on Monday, December 11th. They issued an outperform rating and a $36.00 price target for the company. Piper Jaffray Companies started coverage on shares of Envision Healthcare in a research report on Wednesday, December 13th. They set a neutral rating and a $35.00 price objective for the company. Finally, SunTrust Banks set a $40.00 price objective on shares of Envision Healthcare and gave the stock a buy rating in a research report on Thursday, December 21st. One analyst has rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $42.57.
Shares of Envision Healthcare (NYSE EVHC) opened at $42.89 on Wednesday. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $67.45. The company has a market cap of $5,186.47, a price-to-earnings ratio of 15.89, a P/E/G ratio of 1.07 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a current ratio of 3.40 and a quick ratio of 3.38.
Hedge funds and other institutional investors have recently modified their holdings of the stock. CI Investments Inc. acquired a new stake in Envision Healthcare in the 3rd quarter valued at about $9,084,000. Wells Fargo & Company MN grew its stake in Envision Healthcare by 11.2% in the 3rd quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after acquiring an additional 92,339 shares during the last quarter. OZ Management LP acquired a new stake in Envision Healthcare in the 3rd quarter valued at about $131,987,000. Hexavest Inc. grew its stake in Envision Healthcare by 1.1% in the 4th quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock valued at $22,655,000 after acquiring an additional 7,270 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC grew its stake in Envision Healthcare by 17.9% in the 4th quarter. Quantitative Systematic Strategies LLC now owns 14,319 shares of the company’s stock valued at $495,000 after acquiring an additional 2,169 shares during the last quarter.
TRADEMARK VIOLATION NOTICE: This news story was first reported by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.themarketsdaily.com/2018/03/11/envision-healthcare-evhc-rating-reiterated-by-robert-w-baird-2.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.